Home > Drug Search >
  • company_query: ADC Therapeutics
  •   > 
Drug Filter
Category:
chemistry (7) biology (47)
Status:
Approved (11) NDA Filing (1) BLA Filing (5) Phase Ⅲ (3) Phase Ⅱ (15) Phase Ⅰ (19)
Clinical Stage:
Pending (5) Active (37) Discontinued (1)
Bio-Type:
Vaccine (2) Recombinant enzyme (1) Recombinant polypeptide (1) Recombinant cytokines (16) Recombinant hormone (3) Other recombinant protein (1) Whole antibody (7) Fab fragment (1) Fusion protein (3)
Indication:
Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (2) Anemia (5) Atopic dermatitis (1) Breast cancer (2) Chronic immune thrombocytopenia (1) Chronic lymphocytic leukemia (CLL) (1) Central nervous system cysticercosis (1) Herpes simplex virus (1) Rheumatic disorders (1) Gastric cancer (2) Wet age-related macular degeneration (1) Growth hormone deficit (1) HBV infection (5) HCV infection (6) HIV infection (2) Chemotherapy-induced thrombocytopenia (1) Tumour lysis syndrome (1) Leukemia (1) Lymphoma (2) Melanoma (1) Multiple sclerosis (MS) (1) Myelodysplastic syndrome (MDS) (1) Non-Hodgkin’s lymphoma (NHL) (3) Pancreatic cancer (1) Postmenopausal osteoporosis (1) Psoriasis (1) Rheumatoid arthritis (RA) (3) Solid tumours (3) Thrombocytopenia (1) Type 2 diabetes (1) Colorectal cancer (3) Ankylosing Spondylitis (AS) (1) Varicose ulcer (1) Paroxysmal Nocturnal Hemoglobinuria (PNH) (1) Anthrax (1) Neutropenia (4) Condylomata acuminata (1) Autoimmune diseases (1) Esophageal adenocarcinoma (1) Peritoneum cancer (1) Staphylococcal infection (1) Glioblastoma (1) Graft versus host disease (1) Plaque psoriasis (1) Gout (1) hematological malignancies (1) Ebola virus disease (EVD) (1)
Aprv. Year:
2005 (1) 2015 (1) 2016 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top